420 related articles for article (PubMed ID: 21405971)
1. Lung cancer biomarkers in exhaled breath.
Amann A; Corradi M; Mazzone P; Mutti A
Expert Rev Mol Diagn; 2011 Mar; 11(2):207-17. PubMed ID: 21405971
[TBL] [Abstract][Full Text] [Related]
2. Exhaled biomarkers in lung cancer.
Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G
Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608
[TBL] [Abstract][Full Text] [Related]
3. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W
Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760
[TBL] [Abstract][Full Text] [Related]
4. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
5. [Molecular diagnosis of lung cancer].
Corradi M; Poli D; Goldoni M
G Ital Med Lav Ergon; 2008; 30(3 Suppl):115-6. PubMed ID: 19288801
[TBL] [Abstract][Full Text] [Related]
6. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
7. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
8. Progress in the development of volatile exhaled breath signatures of lung cancer.
Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541
[TBL] [Abstract][Full Text] [Related]
9. Breath testing as a method for detecting lung cancer.
Taivans I; Bukovskis M; Strazda G; Jurka N
Expert Rev Anticancer Ther; 2014 Feb; 14(2):121-3. PubMed ID: 24467216
[TBL] [Abstract][Full Text] [Related]
10. Breath analysis in asbestos-related disorders: a review of the literature and potential future applications.
Chapman EA; Thomas PS; Yates DH
J Breath Res; 2010 Sep; 4(3):034001. PubMed ID: 21383477
[TBL] [Abstract][Full Text] [Related]
11. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
[TBL] [Abstract][Full Text] [Related]
12. A review of novel biological tools used in screening for the early detection of lung cancer.
Ghosal R; Kloer P; Lewis KE
Postgrad Med J; 2009 Jul; 85(1005):358-63. PubMed ID: 19581246
[TBL] [Abstract][Full Text] [Related]
13. Breath carbonyl compounds as biomarkers of lung cancer.
Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers.
McCulloch M; Jezierski T; Broffman M; Hubbard A; Turner K; Janecki T
Integr Cancer Ther; 2006 Mar; 5(1):30-9. PubMed ID: 16484712
[TBL] [Abstract][Full Text] [Related]
15. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
[TBL] [Abstract][Full Text] [Related]
16. Exhaled breath analysis: novel approach for early detection of lung cancer.
Chan HP; Lewis C; Thomas PS
Lung Cancer; 2009 Feb; 63(2):164-8. PubMed ID: 18599152
[TBL] [Abstract][Full Text] [Related]
17. Organic metabolites in exhaled human breath--a multivariate approach for identification of biomarkers in lung disorders.
Gaspar EM; Lucena AF; Duro da Costa J; Chaves das Neves H
J Chromatogr A; 2009 Apr; 1216(14):2749-56. PubMed ID: 19036381
[TBL] [Abstract][Full Text] [Related]
18. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.
Zhou J; Huang ZA; Kumar U; Chen DDY
Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnosis of lung cancer: an overview of recent developments.
Mutti A
Acta Biomed; 2008; 79 Suppl 1():11-23. PubMed ID: 18924306
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease.
Bousamra M; Schumer E; Li M; Knipp RJ; Nantz MH; van Berkel V; Fu XA
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1074-80; discussion 1080-1. PubMed ID: 25129599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
